Although the nature of the current study does not permit us to determine the cause of decreased circulating BMP9 in CHD and HTN patients, we speculate that the decrease of BMP9 in patients with cardiovascular disease might be a defensive response to metabolic stress and arteriosclerosis. Here, GDF2 is linked to hypertensive disorder.